FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Fast Track Status for Crohns Imaging Agent

FDA grants Bracco Imaging a fast-track designation for its BR55 (perfluorobutane/nitrogen lipopeptide-coated microbubbles) injection for detecting are...

latest-news-card-1
Human Drugs

CGMP Violations in Imperial Palace Records

FDA warns Chinas Imperial Palace Commodity about CGMP violations in its manufacturing of over-the-counter drugs.

Biologics

BioStem Illegally Marketing Cellular Products: FDA

FDA warns Pompano Beach, FL-based BioStem Life Sciences that it is illegally marketing cellular products that also reflect CGMP violations.

latest-news-card-1
Medical Devices

Diabetes Device Smartphone Alerts Malfunctioning: FDA

An FDA safety alert on certain diabetes devices that rely on a smartphone to deliver critical safety alerts warns that these may malfunction at times.

latest-news-card-1
Human Drugs

More States Want to Import Drugs: Bloomberg

A Bloomberg Law report says New York is the latest state to indicate an interest in the FDA pathway to import lower-cost drugs from Canada.

latest-news-card-1
Human Drugs

Ziftomenib NDA Due in 2nd Quarter: Kura/Kyowa

Kura Oncology and Kyowa Kurin say they expect to submit a ziftomenib NDA to FDA in the second quarter of 2025.

latest-news-card-1
Medical Devices

Breakthrough Status for ACR-368 OncoSignature Assay

FDA grants Acrivon Therapeutics a breakthrough device designation for the ACR-368 OncoSignature assay, a multiplex immunofluorescence assay for identi...

Medical Devices

Baxter Recalls Life2000 Ventilators

Baxter Healthcare Corporation recalls its Life2000 Ventilator System due to a nonconforming battery charger.

latest-news-card-1
Human Drugs

Monlunabant Trial Misses End Point in Kidney Trial

Novo Nordisk says a recent Phase 2 trial of monlunabant in diabetic kidney disease patients failed to meet its primary endpoint.

latest-news-card-1
Human Drugs

CGMP Issues in China University Contract Lab

FDA warns Chinas Center for Instrumental Analysis of China Pharmaceutical University about CGMP deviations in its work as a contract testing facility ...